This research could lead to advancements in regenerative medicine, especially for those requiring skin grafts or hair ...

Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, is proud to announce that its RENASYS EDGE Negative ...

Common Stock Will Begin Trading on a Split-adjusted Basis on October 18, 2024EDEN PRAIRIE, Minn., Oct. 16, 2024 (GLOBE NEWSWIRE) -- SANUWAVE ...

Medicare reimbursement issues expected for certain of Organogenesis' skin substitute projects disrupting revenues in 2025.